ABC Heart Fail Cardiomyop 2023; 3(2): e20230070
Should Combination of Diuretics Always Be Early after the ADVOR and CLOROTIC Trials?
Nara Kobbaz
, Luana Monferdini, Fernanda Almeida Andrade, Aguinaldo F. Freitas Jr.
There has been remarkable progress in the treatment of heart failure (HF) over the past years. Medications such as angiotensin receptor-neprilysin inhibitors, beta blockers, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter 2 inhibitors (SGLT2i), often referred to as the “fantastic four,” have been shown to reduce mortality and hospitalization, in addition to improving patients’ quality of life.
The natural history of the disease is characterized by recurrent episodes of decompensation and hospital admission linked to pulmonary and/or systemic congestion. Although diuretics doesn’t reduce mortality, they are universally recommended for congestive symptoms relief in all phenotypes of the disease.,
[…]
Keywords: Diuretics; Drug Utilization; Heart Failure
1,436
